ADMA: ADMA Biologics, Inc. Stock

by  •  • Comments Off on ADMA: ADMA Biologics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 5,035.11
Enterprise Value ($M) 5,049.73
Book Value ($M) 231.89
Book Value / Share 0.98
Price / Book 21.71
NCAV ($M) 159.47
NCAV / Share 0.67
Price / NCAV 31.58

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.20
Return on Equity (ROE) 0.45

Liquidity (mrq)
Quick Ratio 3.26
Current Ratio 7.09

Balance Sheet (mrq) ($M)
Current Assets 318.19
Assets 390.62
Liabilities 158.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Vanguard Group Inc 7.77 0.00
11-08 13G Invesco Ltd. 5.50
10-17 13G State Street Corp 5.60
10-07 13G/A BlackRock, Inc. 16.40
09-23 13G Millennium Management Llc 0.60 -78.03
03-11 13G/A Nuveen Asset Management, LLC 2.17 -2.77
03-11 13G/A Tiaa Cref Investment Management Llc 2.17 -2.77
03-11 13G/A Teachers Advisors, Llc 2.17 -2.77
02-14 13G/A Perceptive Advisors Llc 2.80 -45.94

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 277,016 1,595,314 17.36
2024-11-21 310,203 1,771,280 17.51
2024-11-20 274,125 1,768,902 15.50
2024-11-19 339,580 1,698,181 20.00
2024-11-18 410,241 2,190,212 18.73

(click for more detail)

Similar Companies
ACET – Adicet Bio, Inc. ACIU – AC Immune SA
ACRV – Acrivon Therapeutics, Inc. AFMD – Affimed N.V.
ALT – Altimmune, Inc.


Financial data and stock pages provided by
Fintel.io